Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 394

1.

Impact of comorbidities and delay in diagnosis in elderly patients with pulmonary hypertension.

Ginoux M, Turquier S, Chebib N, Glerant JC, Traclet J, Philit F, Sénéchal A, Mornex JF, Cottin V.

ERJ Open Res. 2018 Nov 28;4(4). pii: 00100-2018. doi: 10.1183/23120541.00100-2018. eCollection 2018 Oct.

2.

[Etiological diagnosis of pulmonary hypertension: A cause of difficult diagnosis].

Rigaud P, Traclet J, Cottin V.

Rev Mal Respir. 2018 Nov 22. pii: S0761-8425(18)30999-9. doi: 10.1016/j.rmr.2018.11.004. [Epub ahead of print] French.

PMID:
30473449
3.

Combined pulmonary fibrosis and emphysema in systemic sclerosis: A syndrome associated with heavy morbidity and mortality.

Champtiaux N, Cottin V, Chassagnon G, Chaigne B, Valeyre D, Nunes H, Hachulla E, Launay D, Crestani B, Cazalets C, Jego P, Bussone G, Bérezné A, Guillevin L, Revel MP, Cordier JF, Mouthon L; Groupe d'Etudes et de Recherche sur les Maladies « Orphelines » pulmonaires (GERM«O»P).

Semin Arthritis Rheum. 2018 Oct 13. pii: S0049-0172(17)30511-5. doi: 10.1016/j.semarthrit.2018.10.011. [Epub ahead of print]

PMID:
30409416
4.

Alveolar Hemorrhage in Vasculitis (Primary and Secondary).

Nasser M, Cottin V.

Semin Respir Crit Care Med. 2018 Aug;39(4):482-493. doi: 10.1055/s-0038-1668533. Epub 2018 Nov 7.

PMID:
30404115
5.

12q13.12q13.13 microdeletion encompassing ACVRL1 and SCN8A genes: Clinical report of a new contiguous gene syndrome.

Poisson A, Lesca G, Chatron N, Favre E, Cottin V, Gamondes D, Sanlaville D, Edery P, Giraud S, Demily C, Dupuis-Girod S.

Eur J Med Genet. 2018 Oct 30. pii: S1769-7212(18)30557-3. doi: 10.1016/j.ejmg.2018.10.017. [Epub ahead of print]

PMID:
30389587
6.

Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study.

Cottin V, Koschel D, Günther A, Albera C, Azuma A, Sköld CM, Tomassetti S, Hormel P, Stauffer JL, Strombom I, Kirchgaessler KU, Maher TM.

ERJ Open Res. 2018 Oct 19;4(4). pii: 00084-2018. doi: 10.1183/23120541.00084-2018. eCollection 2018 Oct.

7.

MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.

Juge PA, Lee JS, Ebstein E, Furukawa H, Dobrinskikh E, Gazal S, Kannengiesser C, Ottaviani S, Oka S, Tohma S, Tsuchiya N, Rojas-Serrano J, González-Pérez MI, Mejía M, Buendía-Roldán I, Falfán-Valencia R, Ambrocio-Ortiz E, Manali E, Papiris SA, Karageorgas T, Boumpas D, Antoniou K, van Moorsel CHM, van der Vis J, de Man YA, Grutters JC, Wang Y, Borie R, Wemeau-Stervinou L, Wallaert B, Flipo RM, Nunes H, Valeyre D, Saidenberg-Kermanac'h N, Boissier MC, Marchand-Adam S, Frazier A, Richette P, Allanore Y, Sibilia J, Dromer C, Richez C, Schaeverbeke T, Lioté H, Thabut G, Nathan N, Amselem S, Soubrier M, Cottin V, Clément A, Deane K, Walts AD, Fingerlin T, Fischer A, Ryu JH, Matteson EL, Niewold TB, Assayag D, Gross A, Wolters P, Schwarz MI, Holers M, Solomon JJ, Doyle T, Rosas IO, Blauwendraat C, Nalls MA, Debray MP, Boileau C, Crestani B, Schwartz DA, Dieudé P.

N Engl J Med. 2018 Oct 20. doi: 10.1056/NEJMoa1801562. [Epub ahead of print]

PMID:
30345907
8.

Lung Biopsy in Interstitial Lung Diseases: There Is More than One Way to Cook an Egg.

Nasser M, Cottin V.

Respiration. 2018;96(5):403-405. doi: 10.1159/000493157. Epub 2018 Oct 9. No abstract available.

PMID:
30300902
9.

Dysregulation of the endothelin pathway in lymphangioleiomyomatosis with no direct effect on cell proliferation and migration.

Chebib N, Archer F, Bobet-Erny A, Leroux C, Cottin V.

Sci Rep. 2018 Oct 2;8(1):14698. doi: 10.1038/s41598-018-32795-3.

10.

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial.

Maher TM, Corte TJ, Fischer A, Kreuter M, Lederer DJ, Molina-Molina M, Axmann J, Kirchgaessler KU, Cottin V.

BMJ Open Respir Res. 2018 Sep 4;5(1):e000289. doi: 10.1136/bmjresp-2018-000289. eCollection 2018.

11.

Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension.

Weatherald J, Boucly A, Launay D, Cottin V, Prévot G, Bourlier D, Dauphin C, Chaouat A, Savale L, Jaïs X, Jevnikar M, Traclet J, De Groote P, Simonneau G, Hachulla E, Mouthon L, Montani D, Humbert M, Sitbon O.

Eur Respir J. 2018 Oct 18;52(4). pii: 1800678. doi: 10.1183/13993003.00678-2018. Print 2018 Oct.

PMID:
30209196
12.

TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study.

de Vries PJ, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, Dahlin M, D'Amato L, d'Augères GB, Ferreira JC, Feucht M, Fladrowski C, Hertzberg C, Jozwiak S, Kingswood JC, Lawson JA, Macaya A, Marques R, Nabbout R, O'Callaghan F, Qin J, Sander V, Sauter M, Shah S, Takahashi Y, Touraine R, Youroukos S, Zonnenberg B, Jansen AC; TOSCA Consortium and TOSCA Investigators.

Orphanet J Rare Dis. 2018 Sep 10;13(1):157. doi: 10.1186/s13023-018-0901-8.

13.

Should Patients With Interstitial Lung Disease Be Seen by Experts?

Cottin V, Castillo D, Poletti V, Kreuter M, Corte TJ, Spagnolo P.

Chest. 2018 Sep;154(3):713-714. doi: 10.1016/j.chest.2018.05.044. No abstract available.

PMID:
30195349
14.

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.

Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, Behr J, Cottin V, Danoff SK, Morell F, Flaherty KR, Wells A, Martinez FJ, Azuma A, Bice TJ, Bouros D, Brown KK, Collard HR, Duggal A, Galvin L, Inoue Y, Jenkins RG, Johkoh T, Kazerooni EA, Kitaichi M, Knight SL, Mansour G, Nicholson AG, Pipavath SNJ, Buendía-Roldán I, Selman M, Travis WD, Walsh S, Wilson KC; American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society.

Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST.

PMID:
30168753
15.

Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial.

Maher TM, Stowasser S, Nishioka Y, White ES, Cottin V, Noth I, Selman M, Blahova Z, Wachtlin D, Diefenbach C, Jenkins RG.

BMJ Open Respir Res. 2018 Aug 20;5(1):e000325. doi: 10.1136/bmjresp-2018-000325. eCollection 2018.

16.

Safety of right heart catheterization for pulmonary hypertension in very elderly patients.

Ginoux M, Cottin V, Glérant JC, Traclet J, Philit F, Sénéchal A, Mornex JF, Turquier S.

Pulm Circ. 2018 Oct-Dec;8(4):2045894018799272. doi: 10.1177/2045894018799272. Epub 2018 Aug 20.

17.

Idiopathic pulmonary fibrosis: time for greater expectations?

Wuyts W, Cottin V.

Eur Respir J. 2018 Aug 2;52(2). pii: 1801312. doi: 10.1183/13993003.01312-2018. Print 2018 Aug. No abstract available.

PMID:
30072545
18.

The Respiratory System in Autoimmune Vascular Diseases.

Nasser M, Cottin V.

Respiration. 2018;96(1):12-28. doi: 10.1159/000486899. Epub 2018 Jul 4. Review.

PMID:
29975964
19.

Lung histopathology of non-infectious pulmonary complications after allogeneic haematopoietic stem cell transplantation.

Meignin V, Thivolet-Bejui F, Kambouchner M, Hussenet C, Bondeelle L, Mitchell A, Chagnon K, Begueret H, Segers V, Cottin V, Tazi A, Chevret S, Danel C, Bergeron A.

Histopathology. 2018 Nov;73(5):832-842. doi: 10.1111/his.13697. Epub 2018 Aug 19.

PMID:
29953629
20.

Recent advances in the pathobiology and clinical management of lymphangioleiomyomatosis.

Harari S, Spagnolo P, Cocconcelli E, Luisi F, Cottin V.

Curr Opin Pulm Med. 2018 Sep;24(5):469-476. doi: 10.1097/MCP.0000000000000502.

PMID:
29927757
21.

Pulmonary Arteriovenous Malformation After Metastatic Gestational Trophoblastic Tumor.

Costa C, Massardier J, Gamondes D, Cottin V.

Arch Bronconeumol. 2018 Jun 5. pii: S0300-2896(18)30174-1. doi: 10.1016/j.arbres.2018.04.013. [Epub ahead of print] English, Spanish. No abstract available.

22.

Symptomatic muscular sarcoidosis: Lessons from a nationwide multicenter study.

Cohen Aubart F, Abbara S, Maisonobe T, Cottin V, Papo T, Haroche J, Mathian A, Pha M, Gilardin L, Hervier B, Soussan M, Morlat P, Nunes H, Benveniste O, Amoura Z, Valeyre D.

Neurol Neuroimmunol Neuroinflamm. 2018 Mar 16;5(3):e452. doi: 10.1212/NXI.0000000000000452. eCollection 2018 May.

23.

The Lung in Rheumatoid Arthritis: Focus on Interstitial Lung Disease.

Spagnolo P, Lee JS, Sverzellati N, Rossi G, Cottin V.

Arthritis Rheumatol. 2018 Oct;70(10):1544-1554. doi: 10.1002/art.40574. Epub 2018 Sep 4. Review.

PMID:
29806092
24.

Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis.

Launay D, Montani D, Hassoun PM, Cottin V, Le Pavec J, Clerson P, Sitbon O, Jaïs X, Savale L, Weatherald J, Sobanski V, Mathai SC, Shafiq M, Cordier JF, Hachulla E, Simonneau G, Humbert M.

PLoS One. 2018 May 15;13(5):e0197112. doi: 10.1371/journal.pone.0197112. eCollection 2018.

25.

[Diagnostic uncertainty, working diagnosis and progress of recommendations for pulmonary fibrosis].

Cottin V, Crestani B, Cadranel J, Marchand-Adam S, Prévot G, Wallaert B, Valeyre D.

Rev Mal Respir. 2018 Apr;35(4):479-480. doi: 10.1016/j.rmr.2018.02.007. Epub 2018 May 10. French. No abstract available.

PMID:
29753638
26.

Mortality in systemic necrotizing vasculitides: A retrospective analysis of the French Vasculitis Study Group registry.

Jardel S, Puéchal X, Le Quellec A, Pagnoux C, Hamidou M, Maurier F, Aumaitre O, Aouba A, Quemeneur T, Subra JF, Cottin V, Sibilia J, Godmer P, Cacoub P, Fauchais AL, Hachulla E, Maucort-Boulch D, Guillevin L, Lega JC; French Vasculitis Study Group (FVSG).

Autoimmun Rev. 2018 Jul;17(7):653-659. doi: 10.1016/j.autrev.2018.01.022. Epub 2018 May 3. Review.

PMID:
29730524
27.

Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increase disease Awareness.

Kingswood JC, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, Dahlin M, D' Amato L, d'Augères GB, de Vries PJ, Ferreira JC, Feucht M, Fladrowski C, Hertzberg C, Jozwiak S, Lawson JA, Macaya A, Marques R, Nabbout R, O'Callaghan F, Qin J, Sander V, Sauter M, Shah S, Takahashi Y, Touraine R, Youroukos S, Zonnenberg B, Jansen AC; TOSCA Consortium and TOSCA Investigators.

Nephrol Dial Transplant. 2018 Apr 25. doi: 10.1093/ndt/gfy063. [Epub ahead of print]

PMID:
29697822
28.

Rituximab for auto-immune alveolar proteinosis, a real life cohort study.

Soyez B, Borie R, Menard C, Cadranel J, Chavez L, Cottin V, Gomez E, Marchand-Adam S, Leroy S, Naccache JM, Nunes H, Reynaud-Gaubert M, Savale L, Tazi A, Wemeau-Stervinou L, Debray MP, Crestani B.

Respir Res. 2018 Apr 25;19(1):74. doi: 10.1186/s12931-018-0780-5.

29.

Pulmonary hypertension in chronic lung diseases: comparison to other pulmonary hypertension groups.

Chebib N, Mornex JF, Traclet J, Philit F, Khouatra C, Zeghmar S, Turquier S, Cottin V.

Pulm Circ. 2018 Apr-Jun;8(2):2045894018775056. doi: 10.1177/2045894018775056. Epub 2018 Apr 19.

30.

Pulmonary alveolar proteinosis following cryptococcal meningitis: a possible cause?

Demir S, Chebib N, Thivolet-Bejui F, Cottin V.

BMJ Case Rep. 2018 Mar 28;2018. pii: bcr-2017-222940. doi: 10.1136/bcr-2017-222940.

PMID:
29592982
31.

Interstitial pneumonia with autoimmune features: An update.

Valenzuela C, Cottin V, Ancochea J.

Arch Bronconeumol. 2018 Sep;54(9):447-448. doi: 10.1016/j.arbres.2018.02.003. Epub 2018 Mar 16. English, Spanish. No abstract available.

32.

Whole exome sequencing in three families segregating a pediatric case of sarcoidosis.

Calender A, Rollat Farnier PA, Buisson A, Pinson S, Bentaher A, Lebecque S, Corvol H, Abou Taam R, Houdouin V, Bardel C, Roy P, Devouassoux G, Cottin V, Seve P, Bernaudin JF, Lim CX, Weichhart T, Valeyre D, Pacheco Y, Clement A, Nathan N; in the frame of GSF (Groupe Sarcoïdose France).

BMC Med Genomics. 2018 Mar 6;11(1):23. doi: 10.1186/s12920-018-0338-x.

33.

Effect of cladribine therapy on lung cysts in pulmonary Langerhans cell histiocytosis.

Nasser M, Traclet J, Cottin V.

ERJ Open Res. 2018 Feb 23;4(1). pii: 00089-2017. doi: 10.1183/23120541.00089-2017. eCollection 2018 Jan.

34.

Association between Rheumatoid Arthritis and Pulmonary Hypertension: Data from the French Pulmonary Hypertension Registry.

Montani D, Henry J, O'Connell C, Jaïs X, Cottin V, Launay D, Habib G, Bourdin A, Jevnikar M, Savale L, Rottat L, Simonneau G, Sitbon O, Humbert M, Allanore Y.

Respiration. 2018;95(4):244-250. doi: 10.1159/000485631. Epub 2018 Feb 28.

PMID:
29490304
35.

Presence of Kidney Disease as an Outcome Predictor in Patients with Pulmonary Arterial Hypertension.

Bitker L, Sens F, Payet C, Turquier S, Duclos A, Cottin V, Juillard L.

Am J Nephrol. 2018;47(2):134-143. doi: 10.1159/000487198. Epub 2018 Feb 22.

PMID:
29471290
36.

Safety and efficacy of pirfenidone in patients carrying telomerase complex mutation.

Justet A, Thabut G, Manali E, Molina Molina M, Kannengiesser C, Cadranel J, Cottin V, Gondouin A, Nunes H, Magois E, Tromeur C, Prevot G, Papiris S, Marchand-Adam S, Gamez AS, Reynaud-Gaubert M, Wemeau L, Crestani B, Borie R.

Eur Respir J. 2018 Mar 15;51(3). pii: 1701875. doi: 10.1183/13993003.01875-2017. Print 2018 Mar. No abstract available.

PMID:
29449422
37.

Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study.

Mengoli MC, Rossi G, Cavazza A, Franco R, Marino FZ, Migaldi M, Gnetti L, Silini EM, Ampollini L, Tiseo M, Lococo F, Fournel L, Spagnolo P, Cottin V, Colby TV.

Am J Surg Pathol. 2018 May;42(5):646-655. doi: 10.1097/PAS.0000000000001033.

PMID:
29438170
38.

Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary Fibrosis.

Kreuter M, Costabel U, Richeldi L, Cottin V, Wijsenbeek M, Bonella F, Bendstrup E, Maher TM, Wachtlin D, Stowasser S, Kolb M.

Respiration. 2018;95(5):317-326. doi: 10.1159/000486286. Epub 2018 Feb 7.

PMID:
29414827
39.

Validation of multidisciplinary diagnosis in IPF.

Castillo D, Walsh S, Hansell DM, Vasakova M, Cottin V, Altinisik G, Palmucci S, Sterclova M, Harari S, Richeldi L, Vancheri C, Wells AU; ERICE ILD working group.

Lancet Respir Med. 2018 Feb;6(2):88-89. doi: 10.1016/S2213-2600(18)30023-7. Review. No abstract available.

PMID:
29413085
40.

Mediastinal lymphangioma in an adult.

Nasser M, Ahmad K, Cottin V.

J Thorac Cardiovasc Surg. 2018 Jun;155(6):e195-e197. doi: 10.1016/j.jtcvs.2017.12.119. Epub 2018 Jan 10. No abstract available.

PMID:
29397964
41.

Health economic evaluation in idiopathic pulmonary fibrosis in France.

Porte F, Cottin V, Catella L, Luciani L, Le Lay K, Bénard S.

Curr Med Res Opin. 2018 Oct;34(10):1731-1740. doi: 10.1080/03007995.2018.1433143. Epub 2018 Mar 9.

PMID:
29368948
42.

The unmet medical need of pulmonary hypertension in idiopathic pulmonary fibrosis.

Cottin V, Price LC, Valenzuela C.

Eur Respir J. 2018 Jan 18;51(1). pii: 1702596. doi: 10.1183/13993003.02596-2017. Print 2018 Jan. No abstract available.

PMID:
29348188
43.

Management and attitudes about IPF (Idiopathic Pulmonary Fibrosis) among physicians from Latin America.

Cherrez-Ojeda I, Cottin V, Calderón JC, Delgado C, Calero E, Simanca-Racines D, Quadrelli S, Cherrez A.

BMC Pulm Med. 2018 Jan 10;18(1):5. doi: 10.1186/s12890-017-0569-1.

44.

Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem.

Chebib N, Cottin V, Taharo-Ag-Ralissoum M, Chuzeville M, Mornex JF.

Pulm Circ. 2018 Jan-Mar;8(1):2045893217753352. doi: 10.1177/2045893217753352. Epub 2017 Dec 28. No abstract available.

45.

Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline.

Gupta N, Finlay GA, Kotloff RM, Strange C, Wilson KC, Young LR, Taveira-DaSilva AM, Johnson SR, Cottin V, Sahn SA, Ryu JH, Seyama K, Inoue Y, Downey GP, Han MK, Colby TV, Wikenheiser-Brokamp KA, Meyer CA, Smith K, Moss J, McCormack FX; ATS Assembly on Clinical Problems.

Am J Respir Crit Care Med. 2017 Nov 15;196(10):1337-1348. doi: 10.1164/rccm.201709-1965ST.

46.

[French recommendations for idiopathic pulmonary fibrosis: An updated working document for clinicians].

Cottin V.

Rev Mal Respir. 2017 Oct;34(8):789-790. doi: 10.1016/j.rmr.2017.09.005. French. No abstract available.

PMID:
29102032
47.

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis.

van Manen MJG, Birring SS, Vancheri C, Vindigni V, Renzoni E, Russell AM, Wapenaar M, Cottin V, Wijsenbeek MS.

Eur Respir J. 2017 Oct 19;50(4). pii: 1701157. doi: 10.1183/13993003.01157-2017. Print 2017 Oct. No abstract available.

48.

Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension.

Boucly A, Cottin V, Nunes H, Jaïs X, Tazi A, Prévôt G, Reynaud-Gaubert M, Dromer C, Viacroze C, Horeau-Langlard D, Pison C, Bergot E, Traclet J, Weatherald J, Simonneau G, Valeyre D, Montani D, Humbert M, Sitbon O, Savale L.

Eur Respir J. 2017 Oct 19;50(4). pii: 1700465. doi: 10.1183/13993003.00465-2017. Print 2017 Oct.

PMID:
29051269
49.

Pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia: Correlations between computed tomography findings and cerebral complications.

Etievant J, Si-Mohamed S, Vinurel N, Dupuis-Girod S, Decullier E, Gamondes D, Khouatra C, Cottin V, Revel D.

Eur Radiol. 2018 Mar;28(3):1338-1344. doi: 10.1007/s00330-017-5047-x. Epub 2017 Oct 10.

PMID:
29018941
50.

Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease.

Flaherty KR, Brown KK, Wells AU, Clerisme-Beaty E, Collard HR, Cottin V, Devaraj A, Inoue Y, Le Maulf F, Richeldi L, Schmidt H, Walsh S, Mezzanotte W, Schlenker-Herceg R.

BMJ Open Respir Res. 2017 Sep 17;4(1):e000212. doi: 10.1136/bmjresp-2017-000212. eCollection 2017.

Supplemental Content

Loading ...
Support Center